Bio
Dr. Baker is an Associate Professor of Medicine and Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University. He is an internationally recognized expert in IgG4-related disease and is the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. Dr. Baker received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and a master's degree in Epidemiology and Clinical Research from Stanford University. He completed his residency in Internal Medicine at Massachusetts General Hospital and his fellowship in Rheumatology at Stanford University.
Dr. Baker's research program spans clinical trials, epidemiology, and translational science with the goal of accelerating the development of innovative therapies for immune-mediated diseases. He has designed and led investigator-initiated and industry-sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjögren's disease, and rheumatoid arthritis. His epidemiologic research focuses on defining disease mechanisms, identifying novel therapeutic targets, and repurposing existing medications, including for the treatment of osteoarthritis.
Dr. Baker is also the Co-Founder and Co-Director of the Stanford Immune Reset Program, an interdisciplinary initiative dedicated to advancing transformative therapies with curative potential for autoimmune diseases, including T-cell engagers and in vivo CAR T-cell therapies.
